Dishman Carbogen Amcis has raised Rs 50 crore through the allotment of 5,000 Senior, Secured, Rated, Listed, Transferable, Taxable, Redeemable Non-Convertible Debentures (NCDs) of Rs 1,00,000 each at par for cash, on private placement basis. The Management Committee of Board of Directors has at its meeting held on January 20, 2026 approved allotment of the same.
Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1658.15 |
| Dr. Reddys Lab | 1216.95 |
| Cipla | 1228.20 |
| Zydus Lifesciences | 928.25 |
| Lupin | 2308.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: